Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference


AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2023 financial results on Thursday, February 15, 2024.

AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Thursday, February 15, 2024, to discuss its fourth quarter and full year 2023 financial results. Those interested in listening to the conference call should register online using this link. Participants are encouraged to register more than 15 minutes before the start of the call. A live and replay version of the audio webcast will be available at https://ir.atricure.com/events-and-presentations/events.

AtriCure's management is also scheduled to host investor meetings at the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 13, 2024, in Snowbird, Utah.

About AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure's Isolator® Synergytm Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure's Hybrid AFtm Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure's cryoICE cryoSPHERE® probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.


These press releases may also interest you

at 12:10
Resources Connection, Inc. to Announce Fourth Quarter and Full Fiscal Year 2024 Results on July 18, 2024
Resources Connection, Inc. (the "Company," "we," "us" and "our"), a global consulting firm, will announce results of operations for its fourth quarter and full fiscal year 2024 ended May 25, 2024, after the close of market on Thursday, July 18,...

at 12:05
Transaction in Own Shares
Transaction in Own Shares 3 July, 2024 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Shell plc (the ?Company') announces that on 3 July, 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to...

at 12:01
National Western and Prosperity Life Group Announce Expected Closing Date for $1.9 Billion Cash Merger
National Western Life Group, Inc. ("National Western" or the "Company") , and Prosperity Life Group ("Prosperity Life Group") today announced that the previously announced acquisition of National Western by Prosperity Life Group company S. USA Life...

at 12:00
Hydro-Québec - issue of debentures due February 15, 2063 on the Canadian market
Hydro-Québec announces that it has negotiated on the Canadian domestic market the issue of CA$500,000,000 of Debentures, Series JS, maturing on February 15, 2063. The Debentures, with a coupon of 4.00%, payable semi-annually, will be offered on the...

at 12:00
Steel Dynamics Announces Completion of Note Offering
Steel Dynamics, Inc.  announced today that it has consummated the sale of $600 million aggregate principal amount of 5.375% Notes due 2034 (the "Notes"). The net proceeds from the Notes will be used for general corporate purposes, which may include...

at 11:45
FAT Investors Have Opportunity to Lead FAT Brands Inc. Securities Fraud Lawsuit
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FAT Brands Inc. ("FAT Brands" or "the Company")  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and...

More news about Business...


News published on and distributed by: